Henrik Simonsen
Financieel Directeur/CFO bij ICONOVO AB
Profiel
Henrik Damkjær Simonsen currently works at Iconovo AB, as Chief Financial Officer from 2023.
Mr. Simonsen also formerly worked at Skandinaviska Enskilda Banken AB (Broker Denmark), as Analyst from 2004 to 2011, Nuevolution AB, as Chief Financial Officer, and SAGA Diagnostics AB, as Chief Financial officer.
Mr. Simonsen received his graduate degree from the University of Copenhagen.
Actieve functies van Henrik Simonsen
| Bedrijven | Functie | Begin |
|---|---|---|
| ICONOVO AB | Financieel Directeur/CFO | 01-04-2023 |
Eerdere bekende functies van Henrik Simonsen
| Bedrijven | Functie | Einde |
|---|---|---|
| Skandinaviska Enskilda Banken AB (Broker Denmark) | Analyst-Equity | 01-01-2011 |
SAGA Diagnostics AB
 SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden. | Financieel Directeur/CFO | - |
| NUEVOLUTION AB (PUBL) | Financieel Directeur/CFO | - |
Opleiding van Henrik Simonsen
| University of Copenhagen | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ICONOVO AB | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Skandinaviska Enskilda Banken AB (Broker Denmark) | Finance |
Nuevolution AB
 Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
SAGA Diagnostics AB
SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden. | Health Services |
